Related Experiment Video
Updated: Jul 19, 2025
10:18
From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
13.8K
Intracranial hematolymphoid malignancies: A case series with molecular characterization.
Rebekah G Langston1, Heather Pinckard-Dover1, Grace Guzman1
1Department of Neurosurgery, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Clinical Neurology and Neurosurgery
|August 13, 2023
Summary
Rare central nervous system (CNS) hematologic tumors were surgically resected and characterized. This study reveals unique pathological phenotypes and identifies potential genetic targets for future research in these uncommon CNS hematologic malignancies.
Area of Science:
- Neuro-oncology
- Hematology
- Genomics
Background:
- Central nervous system (CNS) involvement by hematologic malignancies is rare and carries a poor prognosis.
- Surgical intervention for CNS hematologic tumors is infrequent, limiting detailed characterization.
- This study focuses on rare intracranial hematologic tumors requiring surgery.
